BRIEF published on 04/02/2026 at 13:20, 1 month 20 days ago F3 Uranium Corp. Announces C$5 Million Private Placement Deal Private Placement Flow-through Shares Athabasca Basin Red Cloud Securities F3 Uranium Corp.
BRIEF published on 04/02/2026 at 13:20, 1 month 20 days ago F3 Uranium Corp. annonce une opération de placement privé de 5 millions de dollars canadiens Placement Privé Actions Accréditives Bassin D'Athabasca Red Cloud Securities F3 Uranium Corp.
PRESS RELEASE published on 04/02/2026 at 13:15, 1 month 20 days ago F3 Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million F3 Uranium Corp. announces a C$5 million underwritten offering of 25,000,000 flow-through shares at C$0.20 per share for uranium projects in Saskatchewan. Offering managed by Red Cloud Securities Flow-through Shares Red Cloud Securities Underwritten Offering F3 Uranium Corp. Saskatchewan Uranium Projects
Published on 05/23/2026 at 03:15, 4 hours 31 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 4 hours 46 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 5 hours 21 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 5 hours 21 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 6 hours 46 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/22/2026 at 22:05, 9 hours 41 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 9 hours 41 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 11 hours 54 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 13 hours 13 minutes ago Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 13 hours 16 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 19:35, 12 hours 11 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 13 hours 40 minutes ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 13 hours 40 minutes ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 18 hours 53 minutes ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 18 hours 53 minutes ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
